Details for 2017783857

Up to date per 06.04.2026

Actions

Title / Product Name

6,7,8,9-TETRAHYDRO-3H-PYRAZOLO[4,3-F]ISOCHINOLIN-DERIVAT ZUR BEHANDLUNG VON KREBS

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2017783857

EP Publication Number

3433256

E-Number

1163667

Language

PCT Number

EP17076191

Publication Date

30.01.2019 A

07.08.2019 B1

Registration Date

07.08.2019

AT Publication Date

15.08.2019

Application Date

13.10.2017

Registration Number

Priorities

24.10.2016

201662411799 P

16.12.2016

201662435159 P

IPC

C07D 471/04 20060101AFI20180504BHEP

Maximum Duration of Protection

13.10.2037

Owner

Astrazeneca AB 151 85 SödertäljeSE

Representative

Häupl & Ellmeyer KG PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT

Inventor

SCOTT, James, StewartAstraZeneca Darwin Building Cambridge Science Park Milton Road Cambridge Cambridgeshire CB4 0WGGB

BARLAAM, Bernard, ChristopheAstraZeneca Darwin Building Cambridge Science Park Milton Road Cambridge Cambridgeshire CB4 0WGGB

YANG, BinAstraZeneca 35 Gatehouse Drive Waltham, MA 02451US

MOSS, Thomas, AndrewAstraZeneca Darwin Building Darwin Building Cambridge Science Park Milton Road Cambridge Cambridgeshire CB4 0WGGB

HUGHES, Samantha, JayneAstraZeneca Darwin Building Cambridge Science Park Milton Road Cambridge Cambridgeshire CB4 0WGGB

NISSINK, Johannes, Wilhelmus, MariaAstraZeneca Darwin Building Cambridge Science Park Milton Road Cambridge Canbridgeshire CB4 0WGGB

O'DONOVAN, Daniel, HillebrandAstraZeneca Darwin Building Cambridge Science Park Milton Road Cambridge Cambridgeshire CB4 0WGGB

Information about Fees